Skip to main content
  • More from ADA
    • Diabetes Care
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care in Diabetes
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Scientific Sessions Abstracts
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • ADA Scientific Sessions Abstracts
    • Diabetes COVID-19 Article Collection
    • Diabetes Symposium 2020
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • ADA Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes Care
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care in Diabetes
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Diabetes
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Scientific Sessions Abstracts
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • ADA Scientific Sessions Abstracts
    • Diabetes COVID-19 Article Collection
    • Diabetes Symposium 2020
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • ADA Journal Policies
    • Instructions for Authors
    • ADA Peer Review

Index by author

PreviousNext

October 01 1998; volume 47 issue 10

  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

A

  1. Alberiche, M

    1. You have accessRestricted Access
      Prevalence of insulin resistance in metabolic disorders: the Bruneck Study.
      E Bonora, S Kiechl, J Willeit, F Oberhollenzer, G Egger, G Targher, M Alberiche, R C Bonadonna and M Muggeo
      Diabetes 1998 Oct; 47 (10): 1643-1649. https://doi.org/10.2337/diabetes.47.10.1643
      Add to Selected Citations
  2. Andersen, H U

    1. You have accessRestricted Access
      Ciliary neurotrophic factor potentiates the beta-cell inhibitory effect of IL-1beta in rat pancreatic islets associated with increased nitric oxide synthesis and increased expression of inducible nitric oxide synthase.
      K A Wadt, C M Larsen, H U Andersen, K Nielsen, A E Karlsen and T Mandrup-Poulsen
      Diabetes 1998 Oct; 47 (10): 1602-1608. https://doi.org/10.2337/diabetes.47.10.1602
      Add to Selected Citations
  3. Andersen, T

    1. You have accessRestricted Access
      Gln27Glu variant of the human beta2-adrenoreceptor gene is not associated with early-onset obesity in Danish men.
      S M Echwald, T I Sørensen, A Tybjaerg-Hansen, T Andersen and O Pedersen
      Diabetes 1998 Oct; 47 (10): 1657-1658. https://doi.org/10.2337/diabetes.47.10.1657
      Add to Selected Citations
  4. Andersson, A

    1. You have accessRestricted Access
      Capillary blood pressure in syngeneic rat islets transplanted under the renal capsule is similar to that of the implantation organ.
      P O Carlsson, L Jansson, A Andersson and O Källskog
      Diabetes 1998 Oct; 47 (10): 1586-1593. https://doi.org/10.2337/diabetes.47.10.1586
      Add to Selected Citations

B

  1. Barbetti, F

    1. You have accessRestricted Access
      Increased OB gene expression leads to elevated plasma leptin concentrations in patients with chronic primary hyperinsulinemia.
      M D'Adamo, A Buongiorno, E Maroccia, F Leonetti, F Barbetti, A Giaccari, D Zorretta, G Tamburrano and P Sbraccia
      Diabetes 1998 Oct; 47 (10): 1625-1629. https://doi.org/10.2337/diabetes.47.10.1625
      Add to Selected Citations
  2. Bashan, N

    1. You have accessRestricted Access
      Prolonged oxidative stress impairs insulin-induced GLUT4 translocation in 3T3-L1 adipocytes.
      A Rudich, A Tirosh, R Potashnik, R Hemi, H Kanety and N Bashan
      Diabetes 1998 Oct; 47 (10): 1562-1569. https://doi.org/10.2337/diabetes.47.10.1562
      Add to Selected Citations
  3. Behn, P S

    1. You have accessRestricted Access
      Isolation and characterization of the human PAX4 gene.
      T Tao, J Wasson, E Bernal-Mizrachi, P S Behn, S Chayen, L Duprat, J Meyer, B Glaser and M A Permutt
      Diabetes 1998 Oct; 47 (10): 1650-1653. https://doi.org/10.2337/diabetes.47.10.1650
      Add to Selected Citations
  4. Bernal-Mizrachi, E

    1. You have accessRestricted Access
      Isolation and characterization of the human PAX4 gene.
      T Tao, J Wasson, E Bernal-Mizrachi, P S Behn, S Chayen, L Duprat, J Meyer, B Glaser and M A Permutt
      Diabetes 1998 Oct; 47 (10): 1650-1653. https://doi.org/10.2337/diabetes.47.10.1650
      Add to Selected Citations
  5. Boden, G

    1. You have accessRestricted Access
      Acute lowering of plasma fatty acids lowers basal insulin secretion in diabetic and nondiabetic subjects.
      G Boden, X Chen and N Iqbal
      Diabetes 1998 Oct; 47 (10): 1609-1612. https://doi.org/10.2337/diabetes.47.10.1609
      Add to Selected Citations
  6. Boitard, C

    1. You have accessRestricted Access
      No association between the Friedreich's ataxia gene and NIDDM in the French population.
      S Dupont, D Dubois, N Vionnet, C Boitard, S Caillat-Zucman, J Timsit and P Froguel
      Diabetes 1998 Oct; 47 (10): 1654-1656. https://doi.org/10.2337/diabetes.47.10.1654
      Add to Selected Citations
  7. Bonadonna, R C

    1. You have accessRestricted Access
      Prevalence of insulin resistance in metabolic disorders: the Bruneck Study.
      E Bonora, S Kiechl, J Willeit, F Oberhollenzer, G Egger, G Targher, M Alberiche, R C Bonadonna and M Muggeo
      Diabetes 1998 Oct; 47 (10): 1643-1649. https://doi.org/10.2337/diabetes.47.10.1643
      Add to Selected Citations
  8. Bonora, E

    1. You have accessRestricted Access
      Prevalence of insulin resistance in metabolic disorders: the Bruneck Study.
      E Bonora, S Kiechl, J Willeit, F Oberhollenzer, G Egger, G Targher, M Alberiche, R C Bonadonna and M Muggeo
      Diabetes 1998 Oct; 47 (10): 1643-1649. https://doi.org/10.2337/diabetes.47.10.1643
      Add to Selected Citations
  9. Boppart, M D

    1. You have accessRestricted Access
      Epinephrine and insulin stimulate different mitogen-activated protein kinase signaling pathways in rat skeletal muscle.
      R Napoli, L Gibson, M F Hirshman, M D Boppart, S D Dufresne, E S Horton and L J Goodyear
      Diabetes 1998 Oct; 47 (10): 1549-1554. https://doi.org/10.2337/diabetes.47.10.1549
      Add to Selected Citations
  10. Buongiorno, A

    1. You have accessRestricted Access
      Increased OB gene expression leads to elevated plasma leptin concentrations in patients with chronic primary hyperinsulinemia.
      M D'Adamo, A Buongiorno, E Maroccia, F Leonetti, F Barbetti, A Giaccari, D Zorretta, G Tamburrano and P Sbraccia
      Diabetes 1998 Oct; 47 (10): 1625-1629. https://doi.org/10.2337/diabetes.47.10.1625
      Add to Selected Citations
  11. Burk, S H

    1. You have accessRestricted Access
      Plasma glucose levels are reduced in rats and mice treated with an inhibitor of glucose-6-phosphate translocase.
      J C Parker, M A VanVolkenburg, C B Levy, W H Martin, S H Burk, Y Kwon, C Giragossian, T G Gant, P A Carpino, R K McPherson, P Vestergaard and J L Treadway
      Diabetes 1998 Oct; 47 (10): 1630-1636. https://doi.org/10.2337/diabetes.47.10.1630
      Add to Selected Citations

C

  1. Caillat-Zucman, S

    1. You have accessRestricted Access
      No association between the Friedreich's ataxia gene and NIDDM in the French population.
      S Dupont, D Dubois, N Vionnet, C Boitard, S Caillat-Zucman, J Timsit and P Froguel
      Diabetes 1998 Oct; 47 (10): 1654-1656. https://doi.org/10.2337/diabetes.47.10.1654
      Add to Selected Citations
  2. Carlsen, R C

    1. You have accessRestricted Access
      Peripheral neuropathy in transgenic diabetic mice: restoration of C-fiber function with human recombinant nerve growth factor.
      K A Elias, M J Cronin, T A Stewart and R C Carlsen
      Diabetes 1998 Oct; 47 (10): 1637-1642. https://doi.org/10.2337/diabetes.47.10.1637
      Add to Selected Citations
  3. Carlsson, P O

    1. You have accessRestricted Access
      Capillary blood pressure in syngeneic rat islets transplanted under the renal capsule is similar to that of the implantation organ.
      P O Carlsson, L Jansson, A Andersson and O Källskog
      Diabetes 1998 Oct; 47 (10): 1586-1593. https://doi.org/10.2337/diabetes.47.10.1586
      Add to Selected Citations
  4. Carpino, P A

    1. You have accessRestricted Access
      Plasma glucose levels are reduced in rats and mice treated with an inhibitor of glucose-6-phosphate translocase.
      J C Parker, M A VanVolkenburg, C B Levy, W H Martin, S H Burk, Y Kwon, C Giragossian, T G Gant, P A Carpino, R K McPherson, P Vestergaard and J L Treadway
      Diabetes 1998 Oct; 47 (10): 1630-1636. https://doi.org/10.2337/diabetes.47.10.1630
      Add to Selected Citations
  5. Chayen, S

    1. You have accessRestricted Access
      Isolation and characterization of the human PAX4 gene.
      T Tao, J Wasson, E Bernal-Mizrachi, P S Behn, S Chayen, L Duprat, J Meyer, B Glaser and M A Permutt
      Diabetes 1998 Oct; 47 (10): 1650-1653. https://doi.org/10.2337/diabetes.47.10.1650
      Add to Selected Citations
  6. Chen, X

    1. You have accessRestricted Access
      Acute lowering of plasma fatty acids lowers basal insulin secretion in diabetic and nondiabetic subjects.
      G Boden, X Chen and N Iqbal
      Diabetes 1998 Oct; 47 (10): 1609-1612. https://doi.org/10.2337/diabetes.47.10.1609
      Add to Selected Citations
  7. Chester, M W

    1. You have accessRestricted Access
      Circulating fatty acids are essential for efficient glucose-stimulated insulin secretion after prolonged fasting in humans.
      R L Dobbins, M W Chester, M B Daniels, J D McGarry and D T Stein
      Diabetes 1998 Oct; 47 (10): 1613-1618. https://doi.org/10.2337/diabetes.47.10.1613
      Add to Selected Citations
  8. Cronin, M J

    1. You have accessRestricted Access
      Peripheral neuropathy in transgenic diabetic mice: restoration of C-fiber function with human recombinant nerve growth factor.
      K A Elias, M J Cronin, T A Stewart and R C Carlsen
      Diabetes 1998 Oct; 47 (10): 1637-1642. https://doi.org/10.2337/diabetes.47.10.1637
      Add to Selected Citations

D

  1. D'Adamo, M

    1. You have accessRestricted Access
      Increased OB gene expression leads to elevated plasma leptin concentrations in patients with chronic primary hyperinsulinemia.
      M D'Adamo, A Buongiorno, E Maroccia, F Leonetti, F Barbetti, A Giaccari, D Zorretta, G Tamburrano and P Sbraccia
      Diabetes 1998 Oct; 47 (10): 1625-1629. https://doi.org/10.2337/diabetes.47.10.1625
      Add to Selected Citations
  2. Danforth, E

    1. You have accessRestricted Access
      Increase in insulin action and fat oxidation after treatment with CL 316,243, a highly selective beta3-adrenoceptor agonist in humans.
      C Weyer, P A Tataranni, S Snitker, E Danforth and E Ravussin
      Diabetes 1998 Oct; 47 (10): 1555-1561. https://doi.org/10.2337/diabetes.47.10.1555
      Add to Selected Citations
  3. Daniels, M B

    1. You have accessRestricted Access
      Circulating fatty acids are essential for efficient glucose-stimulated insulin secretion after prolonged fasting in humans.
      R L Dobbins, M W Chester, M B Daniels, J D McGarry and D T Stein
      Diabetes 1998 Oct; 47 (10): 1613-1618. https://doi.org/10.2337/diabetes.47.10.1613
      Add to Selected Citations
  4. Dobbins, R L

    1. You have accessRestricted Access
      Circulating fatty acids are essential for efficient glucose-stimulated insulin secretion after prolonged fasting in humans.
      R L Dobbins, M W Chester, M B Daniels, J D McGarry and D T Stein
      Diabetes 1998 Oct; 47 (10): 1613-1618. https://doi.org/10.2337/diabetes.47.10.1613
      Add to Selected Citations
  5. Drijfhout, J W

    1. You have accessRestricted Access
      HLA-DR binding analysis of peptides from islet antigens in IDDM.
      A Geluk, K E van Meijgaarden, N C Schloot, J W Drijfhout, T H Ottenhoff and B O Roep
      Diabetes 1998 Oct; 47 (10): 1594-1601. https://doi.org/10.2337/diabetes.47.10.1594
      Add to Selected Citations
  6. Dubois, D

    1. You have accessRestricted Access
      No association between the Friedreich's ataxia gene and NIDDM in the French population.
      S Dupont, D Dubois, N Vionnet, C Boitard, S Caillat-Zucman, J Timsit and P Froguel
      Diabetes 1998 Oct; 47 (10): 1654-1656. https://doi.org/10.2337/diabetes.47.10.1654
      Add to Selected Citations
  7. Dufresne, S D

    1. You have accessRestricted Access
      Epinephrine and insulin stimulate different mitogen-activated protein kinase signaling pathways in rat skeletal muscle.
      R Napoli, L Gibson, M F Hirshman, M D Boppart, S D Dufresne, E S Horton and L J Goodyear
      Diabetes 1998 Oct; 47 (10): 1549-1554. https://doi.org/10.2337/diabetes.47.10.1549
      Add to Selected Citations
  8. Dupont, S

    1. You have accessRestricted Access
      No association between the Friedreich's ataxia gene and NIDDM in the French population.
      S Dupont, D Dubois, N Vionnet, C Boitard, S Caillat-Zucman, J Timsit and P Froguel
      Diabetes 1998 Oct; 47 (10): 1654-1656. https://doi.org/10.2337/diabetes.47.10.1654
      Add to Selected Citations
  9. Duprat, L

    1. You have accessRestricted Access
      Isolation and characterization of the human PAX4 gene.
      T Tao, J Wasson, E Bernal-Mizrachi, P S Behn, S Chayen, L Duprat, J Meyer, B Glaser and M A Permutt
      Diabetes 1998 Oct; 47 (10): 1650-1653. https://doi.org/10.2337/diabetes.47.10.1650
      Add to Selected Citations

E

  1. Echwald, S M

    1. You have accessRestricted Access
      Gln27Glu variant of the human beta2-adrenoreceptor gene is not associated with early-onset obesity in Danish men.
      S M Echwald, T I Sørensen, A Tybjaerg-Hansen, T Andersen and O Pedersen
      Diabetes 1998 Oct; 47 (10): 1657-1658. https://doi.org/10.2337/diabetes.47.10.1657
      Add to Selected Citations
  2. Egger, G

    1. You have accessRestricted Access
      Prevalence of insulin resistance in metabolic disorders: the Bruneck Study.
      E Bonora, S Kiechl, J Willeit, F Oberhollenzer, G Egger, G Targher, M Alberiche, R C Bonadonna and M Muggeo
      Diabetes 1998 Oct; 47 (10): 1643-1649. https://doi.org/10.2337/diabetes.47.10.1643
      Add to Selected Citations
  3. Elias, K A

    1. You have accessRestricted Access
      Peripheral neuropathy in transgenic diabetic mice: restoration of C-fiber function with human recombinant nerve growth factor.
      K A Elias, M J Cronin, T A Stewart and R C Carlsen
      Diabetes 1998 Oct; 47 (10): 1637-1642. https://doi.org/10.2337/diabetes.47.10.1637
      Add to Selected Citations

F

  1. Flatt, P R

    1. You have accessRestricted Access
      Glycated cholecystokinin-8 has an enhanced satiating activity and is protected against enzymatic degradation.
      F P O'Harte, M H Mooney, C M Kelly and P R Flatt
      Diabetes 1998 Oct; 47 (10): 1619-1624. https://doi.org/10.2337/diabetes.47.10.1619
      Add to Selected Citations
  2. Froguel, P

    1. You have accessRestricted Access
      No association between the Friedreich's ataxia gene and NIDDM in the French population.
      S Dupont, D Dubois, N Vionnet, C Boitard, S Caillat-Zucman, J Timsit and P Froguel
      Diabetes 1998 Oct; 47 (10): 1654-1656. https://doi.org/10.2337/diabetes.47.10.1654
      Add to Selected Citations

G

  1. Gant, T G

    1. You have accessRestricted Access
      Plasma glucose levels are reduced in rats and mice treated with an inhibitor of glucose-6-phosphate translocase.
      J C Parker, M A VanVolkenburg, C B Levy, W H Martin, S H Burk, Y Kwon, C Giragossian, T G Gant, P A Carpino, R K McPherson, P Vestergaard and J L Treadway
      Diabetes 1998 Oct; 47 (10): 1630-1636. https://doi.org/10.2337/diabetes.47.10.1630
      Add to Selected Citations
  2. Geluk, A

    1. You have accessRestricted Access
      HLA-DR binding analysis of peptides from islet antigens in IDDM.
      A Geluk, K E van Meijgaarden, N C Schloot, J W Drijfhout, T H Ottenhoff and B O Roep
      Diabetes 1998 Oct; 47 (10): 1594-1601. https://doi.org/10.2337/diabetes.47.10.1594
      Add to Selected Citations
  3. Giaccari, A

    1. You have accessRestricted Access
      Increased OB gene expression leads to elevated plasma leptin concentrations in patients with chronic primary hyperinsulinemia.
      M D'Adamo, A Buongiorno, E Maroccia, F Leonetti, F Barbetti, A Giaccari, D Zorretta, G Tamburrano and P Sbraccia
      Diabetes 1998 Oct; 47 (10): 1625-1629. https://doi.org/10.2337/diabetes.47.10.1625
      Add to Selected Citations
  4. Gibson, L

    1. You have accessRestricted Access
      Epinephrine and insulin stimulate different mitogen-activated protein kinase signaling pathways in rat skeletal muscle.
      R Napoli, L Gibson, M F Hirshman, M D Boppart, S D Dufresne, E S Horton and L J Goodyear
      Diabetes 1998 Oct; 47 (10): 1549-1554. https://doi.org/10.2337/diabetes.47.10.1549
      Add to Selected Citations
  5. Giragossian, C

    1. You have accessRestricted Access
      Plasma glucose levels are reduced in rats and mice treated with an inhibitor of glucose-6-phosphate translocase.
      J C Parker, M A VanVolkenburg, C B Levy, W H Martin, S H Burk, Y Kwon, C Giragossian, T G Gant, P A Carpino, R K McPherson, P Vestergaard and J L Treadway
      Diabetes 1998 Oct; 47 (10): 1630-1636. https://doi.org/10.2337/diabetes.47.10.1630
      Add to Selected Citations
  6. Glaser, B

    1. You have accessRestricted Access
      Isolation and characterization of the human PAX4 gene.
      T Tao, J Wasson, E Bernal-Mizrachi, P S Behn, S Chayen, L Duprat, J Meyer, B Glaser and M A Permutt
      Diabetes 1998 Oct; 47 (10): 1650-1653. https://doi.org/10.2337/diabetes.47.10.1650
      Add to Selected Citations
  7. Goodyear, L J

    1. You have accessRestricted Access
      Epinephrine and insulin stimulate different mitogen-activated protein kinase signaling pathways in rat skeletal muscle.
      R Napoli, L Gibson, M F Hirshman, M D Boppart, S D Dufresne, E S Horton and L J Goodyear
      Diabetes 1998 Oct; 47 (10): 1549-1554. https://doi.org/10.2337/diabetes.47.10.1549
      Add to Selected Citations

H

  1. Hemi, R

    1. You have accessRestricted Access
      Prolonged oxidative stress impairs insulin-induced GLUT4 translocation in 3T3-L1 adipocytes.
      A Rudich, A Tirosh, R Potashnik, R Hemi, H Kanety and N Bashan
      Diabetes 1998 Oct; 47 (10): 1562-1569. https://doi.org/10.2337/diabetes.47.10.1562
      Add to Selected Citations
  2. Hirshman, M F

    1. You have accessRestricted Access
      Epinephrine and insulin stimulate different mitogen-activated protein kinase signaling pathways in rat skeletal muscle.
      R Napoli, L Gibson, M F Hirshman, M D Boppart, S D Dufresne, E S Horton and L J Goodyear
      Diabetes 1998 Oct; 47 (10): 1549-1554. https://doi.org/10.2337/diabetes.47.10.1549
      Add to Selected Citations
  3. Horton, E S

    1. You have accessRestricted Access
      Epinephrine and insulin stimulate different mitogen-activated protein kinase signaling pathways in rat skeletal muscle.
      R Napoli, L Gibson, M F Hirshman, M D Boppart, S D Dufresne, E S Horton and L J Goodyear
      Diabetes 1998 Oct; 47 (10): 1549-1554. https://doi.org/10.2337/diabetes.47.10.1549
      Add to Selected Citations

I

  1. Iqbal, N

    1. You have accessRestricted Access
      Acute lowering of plasma fatty acids lowers basal insulin secretion in diabetic and nondiabetic subjects.
      G Boden, X Chen and N Iqbal
      Diabetes 1998 Oct; 47 (10): 1609-1612. https://doi.org/10.2337/diabetes.47.10.1609
      Add to Selected Citations

J

  1. Jansson, L

    1. You have accessRestricted Access
      Capillary blood pressure in syngeneic rat islets transplanted under the renal capsule is similar to that of the implantation organ.
      P O Carlsson, L Jansson, A Andersson and O Källskog
      Diabetes 1998 Oct; 47 (10): 1586-1593. https://doi.org/10.2337/diabetes.47.10.1586
      Add to Selected Citations

K

  1. Källskog, O

    1. You have accessRestricted Access
      Capillary blood pressure in syngeneic rat islets transplanted under the renal capsule is similar to that of the implantation organ.
      P O Carlsson, L Jansson, A Andersson and O Källskog
      Diabetes 1998 Oct; 47 (10): 1586-1593. https://doi.org/10.2337/diabetes.47.10.1586
      Add to Selected Citations
  2. Kanety, H

    1. You have accessRestricted Access
      Prolonged oxidative stress impairs insulin-induced GLUT4 translocation in 3T3-L1 adipocytes.
      A Rudich, A Tirosh, R Potashnik, R Hemi, H Kanety and N Bashan
      Diabetes 1998 Oct; 47 (10): 1562-1569. https://doi.org/10.2337/diabetes.47.10.1562
      Add to Selected Citations
  3. Karlsen, A E

    1. You have accessRestricted Access
      Ciliary neurotrophic factor potentiates the beta-cell inhibitory effect of IL-1beta in rat pancreatic islets associated with increased nitric oxide synthesis and increased expression of inducible nitric oxide synthase.
      K A Wadt, C M Larsen, H U Andersen, K Nielsen, A E Karlsen and T Mandrup-Poulsen
      Diabetes 1998 Oct; 47 (10): 1602-1608. https://doi.org/10.2337/diabetes.47.10.1602
      Add to Selected Citations
  4. Kelly, C M

    1. You have accessRestricted Access
      Glycated cholecystokinin-8 has an enhanced satiating activity and is protected against enzymatic degradation.
      F P O'Harte, M H Mooney, C M Kelly and P R Flatt
      Diabetes 1998 Oct; 47 (10): 1619-1624. https://doi.org/10.2337/diabetes.47.10.1619
      Add to Selected Citations
  5. Kiechl, S

    1. You have accessRestricted Access
      Prevalence of insulin resistance in metabolic disorders: the Bruneck Study.
      E Bonora, S Kiechl, J Willeit, F Oberhollenzer, G Egger, G Targher, M Alberiche, R C Bonadonna and M Muggeo
      Diabetes 1998 Oct; 47 (10): 1643-1649. https://doi.org/10.2337/diabetes.47.10.1643
      Add to Selected Citations
  6. Kwon, Y

    1. You have accessRestricted Access
      Plasma glucose levels are reduced in rats and mice treated with an inhibitor of glucose-6-phosphate translocase.
      J C Parker, M A VanVolkenburg, C B Levy, W H Martin, S H Burk, Y Kwon, C Giragossian, T G Gant, P A Carpino, R K McPherson, P Vestergaard and J L Treadway
      Diabetes 1998 Oct; 47 (10): 1630-1636. https://doi.org/10.2337/diabetes.47.10.1630
      Add to Selected Citations

L

  1. Larsen, C M

    1. You have accessRestricted Access
      Ciliary neurotrophic factor potentiates the beta-cell inhibitory effect of IL-1beta in rat pancreatic islets associated with increased nitric oxide synthesis and increased expression of inducible nitric oxide synthase.
      K A Wadt, C M Larsen, H U Andersen, K Nielsen, A E Karlsen and T Mandrup-Poulsen
      Diabetes 1998 Oct; 47 (10): 1602-1608. https://doi.org/10.2337/diabetes.47.10.1602
      Add to Selected Citations
  2. Lenzen, S

    1. You have accessRestricted Access
      Complementary action of antioxidant enzymes in the protection of bioengineered insulin-producing RINm5F cells against the toxicity of reactive oxygen species.
      M Tiedge, S Lortz, R Munday and S Lenzen
      Diabetes 1998 Oct; 47 (10): 1578-1585. https://doi.org/10.2337/diabetes.47.10.1578
      Add to Selected Citations
  3. Leonetti, F

    1. You have accessRestricted Access
      Increased OB gene expression leads to elevated plasma leptin concentrations in patients with chronic primary hyperinsulinemia.
      M D'Adamo, A Buongiorno, E Maroccia, F Leonetti, F Barbetti, A Giaccari, D Zorretta, G Tamburrano and P Sbraccia
      Diabetes 1998 Oct; 47 (10): 1625-1629. https://doi.org/10.2337/diabetes.47.10.1625
      Add to Selected Citations
  4. Levy, C B

    1. You have accessRestricted Access
      Plasma glucose levels are reduced in rats and mice treated with an inhibitor of glucose-6-phosphate translocase.
      J C Parker, M A VanVolkenburg, C B Levy, W H Martin, S H Burk, Y Kwon, C Giragossian, T G Gant, P A Carpino, R K McPherson, P Vestergaard and J L Treadway
      Diabetes 1998 Oct; 47 (10): 1630-1636. https://doi.org/10.2337/diabetes.47.10.1630
      Add to Selected Citations
  5. Liblau, R

    1. You have accessRestricted Access
      Prevention of diabetes in NOD mice by a mutated I-Ab transgene.
      S M Singer, R Tisch, X D Yang, H K Sytwu, R Liblau and H O McDevitt
      Diabetes 1998 Oct; 47 (10): 1570-1577. https://doi.org/10.2337/diabetes.47.10.1570
      Add to Selected Citations
  6. Lortz, S

    1. You have accessRestricted Access
      Complementary action of antioxidant enzymes in the protection of bioengineered insulin-producing RINm5F cells against the toxicity of reactive oxygen species.
      M Tiedge, S Lortz, R Munday and S Lenzen
      Diabetes 1998 Oct; 47 (10): 1578-1585. https://doi.org/10.2337/diabetes.47.10.1578
      Add to Selected Citations

M

  1. Mandrup-Poulsen, T

    1. You have accessRestricted Access
      Apoptosis and the pathogenesis of IDDM: a question of life and death.
      D Mauricio and T Mandrup-Poulsen
      Diabetes 1998 Oct; 47 (10): 1537-1543. https://doi.org/10.2337/diabetes.47.10.1537
      Add to Selected Citations
    2. You have accessRestricted Access
      Ciliary neurotrophic factor potentiates the beta-cell inhibitory effect of IL-1beta in rat pancreatic islets associated with increased nitric oxide synthesis and increased expression of inducible nitric oxide synthase.
      K A Wadt, C M Larsen, H U Andersen, K Nielsen, A E Karlsen and T Mandrup-Poulsen
      Diabetes 1998 Oct; 47 (10): 1602-1608. https://doi.org/10.2337/diabetes.47.10.1602
      Add to Selected Citations
  2. Maroccia, E

    1. You have accessRestricted Access
      Increased OB gene expression leads to elevated plasma leptin concentrations in patients with chronic primary hyperinsulinemia.
      M D'Adamo, A Buongiorno, E Maroccia, F Leonetti, F Barbetti, A Giaccari, D Zorretta, G Tamburrano and P Sbraccia
      Diabetes 1998 Oct; 47 (10): 1625-1629. https://doi.org/10.2337/diabetes.47.10.1625
      Add to Selected Citations
  3. Martin, W H

    1. You have accessRestricted Access
      Plasma glucose levels are reduced in rats and mice treated with an inhibitor of glucose-6-phosphate translocase.
      J C Parker, M A VanVolkenburg, C B Levy, W H Martin, S H Burk, Y Kwon, C Giragossian, T G Gant, P A Carpino, R K McPherson, P Vestergaard and J L Treadway
      Diabetes 1998 Oct; 47 (10): 1630-1636. https://doi.org/10.2337/diabetes.47.10.1630
      Add to Selected Citations
  4. Mauricio, D

    1. You have accessRestricted Access
      Apoptosis and the pathogenesis of IDDM: a question of life and death.
      D Mauricio and T Mandrup-Poulsen
      Diabetes 1998 Oct; 47 (10): 1537-1543. https://doi.org/10.2337/diabetes.47.10.1537
      Add to Selected Citations
  5. McDevitt, H O

    1. You have accessRestricted Access
      Prevention of diabetes in NOD mice by a mutated I-Ab transgene.
      S M Singer, R Tisch, X D Yang, H K Sytwu, R Liblau and H O McDevitt
      Diabetes 1998 Oct; 47 (10): 1570-1577. https://doi.org/10.2337/diabetes.47.10.1570
      Add to Selected Citations
  6. McGarry, J D

    1. You have accessRestricted Access
      Circulating fatty acids are essential for efficient glucose-stimulated insulin secretion after prolonged fasting in humans.
      R L Dobbins, M W Chester, M B Daniels, J D McGarry and D T Stein
      Diabetes 1998 Oct; 47 (10): 1613-1618. https://doi.org/10.2337/diabetes.47.10.1613
      Add to Selected Citations
  7. McPherson, R K

    1. You have accessRestricted Access
      Plasma glucose levels are reduced in rats and mice treated with an inhibitor of glucose-6-phosphate translocase.
      J C Parker, M A VanVolkenburg, C B Levy, W H Martin, S H Burk, Y Kwon, C Giragossian, T G Gant, P A Carpino, R K McPherson, P Vestergaard and J L Treadway
      Diabetes 1998 Oct; 47 (10): 1630-1636. https://doi.org/10.2337/diabetes.47.10.1630
      Add to Selected Citations
  8. Meyer, J

    1. You have accessRestricted Access
      Isolation and characterization of the human PAX4 gene.
      T Tao, J Wasson, E Bernal-Mizrachi, P S Behn, S Chayen, L Duprat, J Meyer, B Glaser and M A Permutt
      Diabetes 1998 Oct; 47 (10): 1650-1653. https://doi.org/10.2337/diabetes.47.10.1650
      Add to Selected Citations
  9. Mooney, M H

    1. You have accessRestricted Access
      Glycated cholecystokinin-8 has an enhanced satiating activity and is protected against enzymatic degradation.
      F P O'Harte, M H Mooney, C M Kelly and P R Flatt
      Diabetes 1998 Oct; 47 (10): 1619-1624. https://doi.org/10.2337/diabetes.47.10.1619
      Add to Selected Citations
  10. Muggeo, M

    1. You have accessRestricted Access
      Prevalence of insulin resistance in metabolic disorders: the Bruneck Study.
      E Bonora, S Kiechl, J Willeit, F Oberhollenzer, G Egger, G Targher, M Alberiche, R C Bonadonna and M Muggeo
      Diabetes 1998 Oct; 47 (10): 1643-1649. https://doi.org/10.2337/diabetes.47.10.1643
      Add to Selected Citations
  11. Munday, R

    1. You have accessRestricted Access
      Complementary action of antioxidant enzymes in the protection of bioengineered insulin-producing RINm5F cells against the toxicity of reactive oxygen species.
      M Tiedge, S Lortz, R Munday and S Lenzen
      Diabetes 1998 Oct; 47 (10): 1578-1585. https://doi.org/10.2337/diabetes.47.10.1578
      Add to Selected Citations

N

  1. Napoli, R

    1. You have accessRestricted Access
      Epinephrine and insulin stimulate different mitogen-activated protein kinase signaling pathways in rat skeletal muscle.
      R Napoli, L Gibson, M F Hirshman, M D Boppart, S D Dufresne, E S Horton and L J Goodyear
      Diabetes 1998 Oct; 47 (10): 1549-1554. https://doi.org/10.2337/diabetes.47.10.1549
      Add to Selected Citations
  2. Nielsen, K

    1. You have accessRestricted Access
      Ciliary neurotrophic factor potentiates the beta-cell inhibitory effect of IL-1beta in rat pancreatic islets associated with increased nitric oxide synthesis and increased expression of inducible nitric oxide synthase.
      K A Wadt, C M Larsen, H U Andersen, K Nielsen, A E Karlsen and T Mandrup-Poulsen
      Diabetes 1998 Oct; 47 (10): 1602-1608. https://doi.org/10.2337/diabetes.47.10.1602
      Add to Selected Citations

O

  1. O'Harte, F P

    1. You have accessRestricted Access
      Glycated cholecystokinin-8 has an enhanced satiating activity and is protected against enzymatic degradation.
      F P O'Harte, M H Mooney, C M Kelly and P R Flatt
      Diabetes 1998 Oct; 47 (10): 1619-1624. https://doi.org/10.2337/diabetes.47.10.1619
      Add to Selected Citations
  2. Oberhollenzer, F

    1. You have accessRestricted Access
      Prevalence of insulin resistance in metabolic disorders: the Bruneck Study.
      E Bonora, S Kiechl, J Willeit, F Oberhollenzer, G Egger, G Targher, M Alberiche, R C Bonadonna and M Muggeo
      Diabetes 1998 Oct; 47 (10): 1643-1649. https://doi.org/10.2337/diabetes.47.10.1643
      Add to Selected Citations
  3. Ottenhoff, T H

    1. You have accessRestricted Access
      HLA-DR binding analysis of peptides from islet antigens in IDDM.
      A Geluk, K E van Meijgaarden, N C Schloot, J W Drijfhout, T H Ottenhoff and B O Roep
      Diabetes 1998 Oct; 47 (10): 1594-1601. https://doi.org/10.2337/diabetes.47.10.1594
      Add to Selected Citations

P

  1. Parker, J C

    1. You have accessRestricted Access
      Plasma glucose levels are reduced in rats and mice treated with an inhibitor of glucose-6-phosphate translocase.
      J C Parker, M A VanVolkenburg, C B Levy, W H Martin, S H Burk, Y Kwon, C Giragossian, T G Gant, P A Carpino, R K McPherson, P Vestergaard and J L Treadway
      Diabetes 1998 Oct; 47 (10): 1630-1636. https://doi.org/10.2337/diabetes.47.10.1630
      Add to Selected Citations
  2. Pedersen, O

    1. You have accessRestricted Access
      Gln27Glu variant of the human beta2-adrenoreceptor gene is not associated with early-onset obesity in Danish men.
      S M Echwald, T I Sørensen, A Tybjaerg-Hansen, T Andersen and O Pedersen
      Diabetes 1998 Oct; 47 (10): 1657-1658. https://doi.org/10.2337/diabetes.47.10.1657
      Add to Selected Citations
  3. Permutt, M A

    1. You have accessRestricted Access
      Isolation and characterization of the human PAX4 gene.
      T Tao, J Wasson, E Bernal-Mizrachi, P S Behn, S Chayen, L Duprat, J Meyer, B Glaser and M A Permutt
      Diabetes 1998 Oct; 47 (10): 1650-1653. https://doi.org/10.2337/diabetes.47.10.1650
      Add to Selected Citations
  4. Potashnik, R

    1. You have accessRestricted Access
      Prolonged oxidative stress impairs insulin-induced GLUT4 translocation in 3T3-L1 adipocytes.
      A Rudich, A Tirosh, R Potashnik, R Hemi, H Kanety and N Bashan
      Diabetes 1998 Oct; 47 (10): 1562-1569. https://doi.org/10.2337/diabetes.47.10.1562
      Add to Selected Citations

R

  1. Ravussin, E

    1. You have accessRestricted Access
      Increase in insulin action and fat oxidation after treatment with CL 316,243, a highly selective beta3-adrenoceptor agonist in humans.
      C Weyer, P A Tataranni, S Snitker, E Danforth and E Ravussin
      Diabetes 1998 Oct; 47 (10): 1555-1561. https://doi.org/10.2337/diabetes.47.10.1555
      Add to Selected Citations
  2. Roep, B O

    1. You have accessRestricted Access
      HLA-DR binding analysis of peptides from islet antigens in IDDM.
      A Geluk, K E van Meijgaarden, N C Schloot, J W Drijfhout, T H Ottenhoff and B O Roep
      Diabetes 1998 Oct; 47 (10): 1594-1601. https://doi.org/10.2337/diabetes.47.10.1594
      Add to Selected Citations
  3. Rudich, A

    1. You have accessRestricted Access
      Prolonged oxidative stress impairs insulin-induced GLUT4 translocation in 3T3-L1 adipocytes.
      A Rudich, A Tirosh, R Potashnik, R Hemi, H Kanety and N Bashan
      Diabetes 1998 Oct; 47 (10): 1562-1569. https://doi.org/10.2337/diabetes.47.10.1562
      Add to Selected Citations

S

  1. Sbraccia, P

    1. You have accessRestricted Access
      Increased OB gene expression leads to elevated plasma leptin concentrations in patients with chronic primary hyperinsulinemia.
      M D'Adamo, A Buongiorno, E Maroccia, F Leonetti, F Barbetti, A Giaccari, D Zorretta, G Tamburrano and P Sbraccia
      Diabetes 1998 Oct; 47 (10): 1625-1629. https://doi.org/10.2337/diabetes.47.10.1625
      Add to Selected Citations
  2. Schloot, N C

    1. You have accessRestricted Access
      HLA-DR binding analysis of peptides from islet antigens in IDDM.
      A Geluk, K E van Meijgaarden, N C Schloot, J W Drijfhout, T H Ottenhoff and B O Roep
      Diabetes 1998 Oct; 47 (10): 1594-1601. https://doi.org/10.2337/diabetes.47.10.1594
      Add to Selected Citations
  3. Singer, S M

    1. You have accessRestricted Access
      Prevention of diabetes in NOD mice by a mutated I-Ab transgene.
      S M Singer, R Tisch, X D Yang, H K Sytwu, R Liblau and H O McDevitt
      Diabetes 1998 Oct; 47 (10): 1570-1577. https://doi.org/10.2337/diabetes.47.10.1570
      Add to Selected Citations
  4. Snitker, S

    1. You have accessRestricted Access
      Increase in insulin action and fat oxidation after treatment with CL 316,243, a highly selective beta3-adrenoceptor agonist in humans.
      C Weyer, P A Tataranni, S Snitker, E Danforth and E Ravussin
      Diabetes 1998 Oct; 47 (10): 1555-1561. https://doi.org/10.2337/diabetes.47.10.1555
      Add to Selected Citations
  5. Sørensen, T I

    1. You have accessRestricted Access
      Gln27Glu variant of the human beta2-adrenoreceptor gene is not associated with early-onset obesity in Danish men.
      S M Echwald, T I Sørensen, A Tybjaerg-Hansen, T Andersen and O Pedersen
      Diabetes 1998 Oct; 47 (10): 1657-1658. https://doi.org/10.2337/diabetes.47.10.1657
      Add to Selected Citations
  6. Stein, D T

    1. You have accessRestricted Access
      Circulating fatty acids are essential for efficient glucose-stimulated insulin secretion after prolonged fasting in humans.
      R L Dobbins, M W Chester, M B Daniels, J D McGarry and D T Stein
      Diabetes 1998 Oct; 47 (10): 1613-1618. https://doi.org/10.2337/diabetes.47.10.1613
      Add to Selected Citations
  7. Stewart, T A

    1. You have accessRestricted Access
      Peripheral neuropathy in transgenic diabetic mice: restoration of C-fiber function with human recombinant nerve growth factor.
      K A Elias, M J Cronin, T A Stewart and R C Carlsen
      Diabetes 1998 Oct; 47 (10): 1637-1642. https://doi.org/10.2337/diabetes.47.10.1637
      Add to Selected Citations
  8. Sytwu, H K

    1. You have accessRestricted Access
      Prevention of diabetes in NOD mice by a mutated I-Ab transgene.
      S M Singer, R Tisch, X D Yang, H K Sytwu, R Liblau and H O McDevitt
      Diabetes 1998 Oct; 47 (10): 1570-1577. https://doi.org/10.2337/diabetes.47.10.1570
      Add to Selected Citations

T

  1. Tamburrano, G

    1. You have accessRestricted Access
      Increased OB gene expression leads to elevated plasma leptin concentrations in patients with chronic primary hyperinsulinemia.
      M D'Adamo, A Buongiorno, E Maroccia, F Leonetti, F Barbetti, A Giaccari, D Zorretta, G Tamburrano and P Sbraccia
      Diabetes 1998 Oct; 47 (10): 1625-1629. https://doi.org/10.2337/diabetes.47.10.1625
      Add to Selected Citations
  2. Tao, T

    1. You have accessRestricted Access
      Isolation and characterization of the human PAX4 gene.
      T Tao, J Wasson, E Bernal-Mizrachi, P S Behn, S Chayen, L Duprat, J Meyer, B Glaser and M A Permutt
      Diabetes 1998 Oct; 47 (10): 1650-1653. https://doi.org/10.2337/diabetes.47.10.1650
      Add to Selected Citations
  3. Targher, G

    1. You have accessRestricted Access
      Prevalence of insulin resistance in metabolic disorders: the Bruneck Study.
      E Bonora, S Kiechl, J Willeit, F Oberhollenzer, G Egger, G Targher, M Alberiche, R C Bonadonna and M Muggeo
      Diabetes 1998 Oct; 47 (10): 1643-1649. https://doi.org/10.2337/diabetes.47.10.1643
      Add to Selected Citations
  4. Tataranni, P A

    1. You have accessRestricted Access
      Increase in insulin action and fat oxidation after treatment with CL 316,243, a highly selective beta3-adrenoceptor agonist in humans.
      C Weyer, P A Tataranni, S Snitker, E Danforth and E Ravussin
      Diabetes 1998 Oct; 47 (10): 1555-1561. https://doi.org/10.2337/diabetes.47.10.1555
      Add to Selected Citations
  5. Tiedge, M

    1. You have accessRestricted Access
      Complementary action of antioxidant enzymes in the protection of bioengineered insulin-producing RINm5F cells against the toxicity of reactive oxygen species.
      M Tiedge, S Lortz, R Munday and S Lenzen
      Diabetes 1998 Oct; 47 (10): 1578-1585. https://doi.org/10.2337/diabetes.47.10.1578
      Add to Selected Citations
  6. Timsit, J

    1. You have accessRestricted Access
      No association between the Friedreich's ataxia gene and NIDDM in the French population.
      S Dupont, D Dubois, N Vionnet, C Boitard, S Caillat-Zucman, J Timsit and P Froguel
      Diabetes 1998 Oct; 47 (10): 1654-1656. https://doi.org/10.2337/diabetes.47.10.1654
      Add to Selected Citations
  7. Tirosh, A

    1. You have accessRestricted Access
      Prolonged oxidative stress impairs insulin-induced GLUT4 translocation in 3T3-L1 adipocytes.
      A Rudich, A Tirosh, R Potashnik, R Hemi, H Kanety and N Bashan
      Diabetes 1998 Oct; 47 (10): 1562-1569. https://doi.org/10.2337/diabetes.47.10.1562
      Add to Selected Citations
  8. Tisch, R

    1. You have accessRestricted Access
      Prevention of diabetes in NOD mice by a mutated I-Ab transgene.
      S M Singer, R Tisch, X D Yang, H K Sytwu, R Liblau and H O McDevitt
      Diabetes 1998 Oct; 47 (10): 1570-1577. https://doi.org/10.2337/diabetes.47.10.1570
      Add to Selected Citations
  9. Treadway, J L

    1. You have accessRestricted Access
      Plasma glucose levels are reduced in rats and mice treated with an inhibitor of glucose-6-phosphate translocase.
      J C Parker, M A VanVolkenburg, C B Levy, W H Martin, S H Burk, Y Kwon, C Giragossian, T G Gant, P A Carpino, R K McPherson, P Vestergaard and J L Treadway
      Diabetes 1998 Oct; 47 (10): 1630-1636. https://doi.org/10.2337/diabetes.47.10.1630
      Add to Selected Citations
  10. Tybjaerg-Hansen, A

    1. You have accessRestricted Access
      Gln27Glu variant of the human beta2-adrenoreceptor gene is not associated with early-onset obesity in Danish men.
      S M Echwald, T I Sørensen, A Tybjaerg-Hansen, T Andersen and O Pedersen
      Diabetes 1998 Oct; 47 (10): 1657-1658. https://doi.org/10.2337/diabetes.47.10.1657
      Add to Selected Citations

V

  1. van Meijgaarden, K E

    1. You have accessRestricted Access
      HLA-DR binding analysis of peptides from islet antigens in IDDM.
      A Geluk, K E van Meijgaarden, N C Schloot, J W Drijfhout, T H Ottenhoff and B O Roep
      Diabetes 1998 Oct; 47 (10): 1594-1601. https://doi.org/10.2337/diabetes.47.10.1594
      Add to Selected Citations
  2. VanVolkenburg, M A

    1. You have accessRestricted Access
      Plasma glucose levels are reduced in rats and mice treated with an inhibitor of glucose-6-phosphate translocase.
      J C Parker, M A VanVolkenburg, C B Levy, W H Martin, S H Burk, Y Kwon, C Giragossian, T G Gant, P A Carpino, R K McPherson, P Vestergaard and J L Treadway
      Diabetes 1998 Oct; 47 (10): 1630-1636. https://doi.org/10.2337/diabetes.47.10.1630
      Add to Selected Citations
  3. Vestergaard, P

    1. You have accessRestricted Access
      Plasma glucose levels are reduced in rats and mice treated with an inhibitor of glucose-6-phosphate translocase.
      J C Parker, M A VanVolkenburg, C B Levy, W H Martin, S H Burk, Y Kwon, C Giragossian, T G Gant, P A Carpino, R K McPherson, P Vestergaard and J L Treadway
      Diabetes 1998 Oct; 47 (10): 1630-1636. https://doi.org/10.2337/diabetes.47.10.1630
      Add to Selected Citations
  4. Vionnet, N

    1. You have accessRestricted Access
      No association between the Friedreich's ataxia gene and NIDDM in the French population.
      S Dupont, D Dubois, N Vionnet, C Boitard, S Caillat-Zucman, J Timsit and P Froguel
      Diabetes 1998 Oct; 47 (10): 1654-1656. https://doi.org/10.2337/diabetes.47.10.1654
      Add to Selected Citations

W

  1. Wadt, K A

    1. You have accessRestricted Access
      Ciliary neurotrophic factor potentiates the beta-cell inhibitory effect of IL-1beta in rat pancreatic islets associated with increased nitric oxide synthesis and increased expression of inducible nitric oxide synthase.
      K A Wadt, C M Larsen, H U Andersen, K Nielsen, A E Karlsen and T Mandrup-Poulsen
      Diabetes 1998 Oct; 47 (10): 1602-1608. https://doi.org/10.2337/diabetes.47.10.1602
      Add to Selected Citations
  2. Wasson, J

    1. You have accessRestricted Access
      Isolation and characterization of the human PAX4 gene.
      T Tao, J Wasson, E Bernal-Mizrachi, P S Behn, S Chayen, L Duprat, J Meyer, B Glaser and M A Permutt
      Diabetes 1998 Oct; 47 (10): 1650-1653. https://doi.org/10.2337/diabetes.47.10.1650
      Add to Selected Citations
  3. Weyer, C

    1. You have accessRestricted Access
      Increase in insulin action and fat oxidation after treatment with CL 316,243, a highly selective beta3-adrenoceptor agonist in humans.
      C Weyer, P A Tataranni, S Snitker, E Danforth and E Ravussin
      Diabetes 1998 Oct; 47 (10): 1555-1561. https://doi.org/10.2337/diabetes.47.10.1555
      Add to Selected Citations
  4. Willeit, J

    1. You have accessRestricted Access
      Prevalence of insulin resistance in metabolic disorders: the Bruneck Study.
      E Bonora, S Kiechl, J Willeit, F Oberhollenzer, G Egger, G Targher, M Alberiche, R C Bonadonna and M Muggeo
      Diabetes 1998 Oct; 47 (10): 1643-1649. https://doi.org/10.2337/diabetes.47.10.1643
      Add to Selected Citations
  5. Wilson, J E

    1. You have accessRestricted Access
      Distinguishing the type I and type II isozymes of hexokinase: the need for a reexamination of past practice.
      J E Wilson
      Diabetes 1998 Oct; 47 (10): 1544-1548. https://doi.org/10.2337/diabetes.47.10.1544
      Add to Selected Citations

Y

  1. Yang, X D

    1. You have accessRestricted Access
      Prevention of diabetes in NOD mice by a mutated I-Ab transgene.
      S M Singer, R Tisch, X D Yang, H K Sytwu, R Liblau and H O McDevitt
      Diabetes 1998 Oct; 47 (10): 1570-1577. https://doi.org/10.2337/diabetes.47.10.1570
      Add to Selected Citations

Z

  1. Zorretta, D

    1. You have accessRestricted Access
      Increased OB gene expression leads to elevated plasma leptin concentrations in patients with chronic primary hyperinsulinemia.
      M D'Adamo, A Buongiorno, E Maroccia, F Leonetti, F Barbetti, A Giaccari, D Zorretta, G Tamburrano and P Sbraccia
      Diabetes 1998 Oct; 47 (10): 1625-1629. https://doi.org/10.2337/diabetes.47.10.1625
      Add to Selected Citations
Back to top
PreviousNext

In this Issue

October 1998, 47(10)
  • Table of Contents
  • Index by Author
Sign up to receive current issue alerts
View Selected Citations (0)
  • Most Read
  • Most Cited
Loading
  • Differentiation of Diabetes by Pathophysiology, Natural History, and Prognosis
  • Latent Autoimmune Diabetes in Adults
  • Poverty and Obesity in the U.S.
  • The Multiple Actions of GLP-1 on the Process of Glucose-Stimulated Insulin Secretion
  • A Polymorphism in the Glucocorticoid Receptor Gene, Which Decreases Sensitivity to Glucocorticoids In Vivo, Is Associated With Low Insulin and Cholesterol Levels
More...

Navigate

  • Current Issue
  • Online Ahead of Print
  • Scientific Sessions Abstracts
  • Collections
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • Advertising
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes Care
  • Clinical Diabetes
  • Diabetes Spectrum
  • Scientific Sessions Abstracts
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org

© 2021 by the American Diabetes Association. Diabetes Print ISSN: 0012-1797, Online ISSN: 1939-327X.